{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:38:09Z","timestamp":1792269489477,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"DOI":"10.7759\/cureus.115383","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:38:27Z","timestamp":1787985507000},"source":"Crossref","is-referenced-by-count":1,"title":["Leflunomide-Induced Severe Cutaneous Adverse Reaction, Severe Drug-Induced Liver Injury With Hepatic Encephalopathy, and Hemophagocytic Lymphohistiocytosis: A Case Report"],"prefix":"10.7759","author":[{"given":"Kiran Prasad","family":"Moparthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyavani","family":"Jampani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69309-z","article-title":"Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study","volume":"10","author":"Deng D","year":"2020","unstructured":"Deng D, Zhou J, Li M, et al.. Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study. Sci Rep. 2020, 10:12339. 10.1038\/s41598-020-69309-z","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00307-9","article-title":"Histiocytic disorders","volume":"7","author":"McClain KL","year":"2021","unstructured":"McClain KL, Bigenwald C, Collin M, et al.. Histiocytic disorders. Nat Rev Dis Primers. 2021, 7:73. 10.1038\/s41572-021-00307-9","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12659\/ajcr.907464","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to furosemide: case report and review of literature","volume":"19","author":"James J","year":"2018","unstructured":"James J, Sammour YM, Virata AR, Nordin TA, Dumic I. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to furosemide: case report and review of literature. Am J Case Rep. 2018, 19:163-70. 10.12659\/ajcr.907464","journal-title":"Am J Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11020346","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): focus on the pathophysiological and diagnostic role of viruses","volume":"11","author":"Ramirez GA","year":"2023","unstructured":"Ramirez GA, Ripa M, Burastero S, et al.. Drug reaction with eosinophilia and systemic symptoms (DRESS): focus on the pathophysiological and diagnostic role of viruses. Microorganisms. 2023, 11:346. 10.3390\/microorganisms11020346","journal-title":"Microorganisms"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13298","article-title":"Hemophagocytic lymphohistiocytosis: a disorder of T cell activation, immune regulation, and distinctive immunopathology","volume":"322","author":"Jordan MB","year":"2024","unstructured":"Jordan MB. Hemophagocytic lymphohistiocytosis: a disorder of T cell activation, immune regulation, and distinctive immunopathology. Immunol Rev. 2024, 322:339-50. 10.1111\/imr.13298","journal-title":"Immunol Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.608492","article-title":"Novel therapeutic approaches to familial HLH (emapalumab in FHL)","volume":"11","author":"Merli P","year":"2020","unstructured":"Merli P, Algeri M, Gaspari S, Locatelli F. Novel therapeutic approaches to familial HLH (emapalumab in FHL). Front Immunol. 2020, 11:608492. 10.3389\/fimmu.2020.608492","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun SH","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2007, 156:609-11. 10.1111\/j.1365-2133.2006.07704.x","journal-title":"Br J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara T","year":"2006","unstructured":"Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int. 2006, 55:1-8. 10.2332\/allergolint.55.1","journal-title":"Allergol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet L","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, et al.. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014, 66:2613-20. 10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15189","article-title":"Leflunomide-induced liver injury: differences in characteristics and outcomes in Indian and US registries","volume":"42","author":"Devarbhavi H","year":"2022","unstructured":"Devarbhavi H, Ghabril M, Barnhart H, et al.. Leflunomide-induced liver injury: differences in characteristics and outcomes in Indian and US registries. Liver Int. 2022, 42:1323-9. 10.1111\/liv.15189","journal-title":"Liver Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107398","article-title":"Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: a comprehensive review","volume":"93","author":"Alamri RD","year":"2021","unstructured":"Alamri RD, Elmeligy MA, Albalawi GA, Alquayr SM, Alsubhi SS, El-Ghaiesh SH. Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: a comprehensive review. Int Immunopharmacol. 2021, 93:107398. 10.1016\/j.intimp.2021.107398","journal-title":"Int Immunopharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184287","article-title":"Less known gastrointestinal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review of the literature","volume":"10","author":"Jevtic D","year":"2021","unstructured":"Jevtic D, Dumic I, Nordin T, et al.. Less known gastrointestinal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review of the literature. J Clin Med. 2021, 10:4287. 10.3390\/jcm10184287","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.927951","article-title":"Complicated drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome history in a 14-year-old","volume":"22","author":"Tomani M","year":"2021","unstructured":"Tomani M, Caridi C, Tatarina-Nulman O, Charlot C, Narula P. Complicated drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome history in a 14-year-old. Am J Case Rep. 2021, 22:e927951. 10.12659\/AJCR.927951","journal-title":"Am J Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin G","year":"2020","unstructured":"Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020, 34:101515. 10.1016\/j.berh.2020.101515","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4274\/balkanmedj.galenos.2022.2022-4-83","article-title":"Hemophagocytic lymphohistiocytosis","volume":"39","author":"Ka\u00e7ar AG","year":"2022","unstructured":"Ka\u00e7ar AG, Celkan TT. Hemophagocytic lymphohistiocytosis. Balkan Med J. 2022, 39:309-17. 10.4274\/balkanmedj.galenos.2022.2022-4-83","journal-title":"Balkan Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-021-00348-z","article-title":"Updates and insights in the diagnosis and management of DRESS syndrome","volume":"10","author":"Schunkert EM","year":"2021","unstructured":"Schunkert EM, Divito SJ. Updates and insights in the diagnosis and management of DRESS syndrome. Curr Dermatol Rep. 2021, 10:192-204. 10.1007\/s13671-021-00348-z","journal-title":"Curr Dermatol Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115921","article-title":"Pathogenesis of hemophagocytic lymphohistiocytosis \/ macrophage activation syndrome: a case report and review of the literature","volume":"25","author":"Gioia C","year":"2024","unstructured":"Gioia C, Paroli M, Izzo R, Di Sanzo L, Rossi E, Pignatelli P, Accapezzato D. Pathogenesis of hemophagocytic lymphohistiocytosis \/ macrophage activation syndrome: a case report and review of the literature. Int J Mol Sci. 2024, 25:5921. 10.3390\/ijms25115921","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1737684","article-title":"Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis","volume":"61","author":"Bubik RJ","year":"2020","unstructured":"Bubik RJ, Barth DM, Hook C, et al.. Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis. Leuk Lymphoma. 2020, 61:1592-600. 10.1080\/10428194.2020.1737684","journal-title":"Leuk Lymphoma"},{"key":"ref20","article-title":"Leflunomide","author":"Hoofnagle JH","year":"2012","unstructured":"Hoofnagle JH. Leflunomide. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD); 2012."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/267170-leflunomide-induced-severe-cutaneous-adverse-reaction-severe-drug-induced-liver-injury-with-hepatic-encephalopathy-and-hemophagocytic-lymphohistiocytosis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:38:29Z","timestamp":1787985509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/267170-leflunomide-induced-severe-cutaneous-adverse-reaction-severe-drug-induced-liver-injury-with-hepatic-encephalopathy-and-hemophagocytic-lymphohistiocytosis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.115383","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}